Interview Questions159

    Insurance M&A: Underwriter Acquisitions vs. Broker Roll-Ups

    Insurance M&A explained: carrier deals priced on reserves and capital vs broker roll-ups at 11-16x EBITDA, and why the roll-up arbitrage has narrowed.

    |
    8 min read
    |
    1 interview question
    |
    Share

    Introduction

    Insurance M&A encompasses two fundamentally different transaction types that share almost nothing in common analytically. Underwriter (carrier) acquisitions are balance-sheet transactions evaluated on reserve adequacy, embedded value, loss ratios, and capital requirements. Broker (distributor) acquisitions are cash-flow transactions evaluated on EV/EBITDA multiples, recurring revenue quality, and customer retention. The analytical frameworks, valuation methodologies, and buyer universes are entirely distinct. For FIG bankers, insurance M&A advisory requires mastering both frameworks: broker deals are far more numerous, carrier deals are fewer but often larger and more complex, and the advisory approach for each is fundamentally different.

    Underwriter/Carrier Acquisitions

    Carrier M&A involves acquiring the insurance company itself: its balance sheet, reserves, investment portfolio, policy liabilities, and regulatory licenses. In 2024, North American underwriter M&A totaled $21.95 billion across 85 deals, a 44% increase from $15.21 billion in 2023.

    The evaluation of a carrier acquisition centers on the balance sheet. The acquirer must assess whether reserves are adequately stated (under-reserved targets create hidden liabilities that surface post-close as adverse reserve development). Embedded value (for life insurers) quantifies the present value of future profits locked in existing policies. The combined ratio reveals underwriting profitability. And the capital position (RBC ratio in the US, Solvency II ratio in Europe) determines how much capital is available for deployment versus how much is trapped to support existing liabilities.

    Recent notable carrier deals reflect several strategic themes, led by Japanese insurers buying US growth. Nippon Life completed its $3.8 billion purchase of a 20% stake in Corebridge Financial, AIG's former life and retirement subsidiary, in December 2024. Meiji Yasuda's StanCorp agreed in 2024 to buy Allstate's employer voluntary benefits business for about $2 billion (closed April 2025), then the parent agreed in February 2025 to buy Legal & General's US protection business for $2.3 billion. In specialty P&C, Sompo completed its $3.5 billion takeover of Aspen Insurance in February 2026. These cross-border transactions are driven by demographic headwinds in Japan (aging population, shrinking insurance market) pushing Japanese carriers to seek growth in the US.

    Reserve Analysis in Carrier M&A

    Reserve analysis is the most critical due diligence workstream in an insurance carrier acquisition. The acquirer (typically through independent actuaries) performs a comprehensive review of the target's loss and loss adjustment expense reserves across every line of business. The analysis identifies whether reserves are redundant (overstated, creating a hidden cushion) or deficient (understated, creating a hidden liability). Reserve redundancy benefits the acquirer because it will eventually flow through as favorable development, boosting future earnings. Reserve deficiency is destructive: it means the target's reported earnings were overstated, and future adverse development will reduce the acquirer's profitability. A $500 million reserve deficiency on a $5 billion acquisition effectively increases the true cost to $5.5 billion. This is why FIG bankers working on carrier deals coordinate closely with actuarial advisors, and why carrier deal pricing often includes purchase price adjustments tied to reserve adequacy assessments completed post-close.

    Carrier deals also involve reinsurance portfolio optimization. The acquirer evaluates the target's ceded reinsurance program (how much risk is passed to reinsurers, at what cost, and how the program compares to the acquirer's own reinsurance structure). Post-acquisition, the combined entity often restructures its reinsurance to achieve better terms, reduce redundant coverage, or access capacity that neither entity could access independently.

    Broker/Distributor Acquisitions: The Roll-Up Machine

    Broker M&A is a completely different animal. Brokers are capital-light, fee-based businesses that generate revenue from commissions and advisory fees for placing insurance on behalf of clients. They hold no underwriting risk, maintain no reserves, and require minimal regulatory capital. This capital-light profile makes them ideal candidates for PE-driven consolidation.

    OPTIS Partners counted 695 North American agent and broker deals in 2025, down 12% from 787 in 2024, with private equity-backed and hybrid buyers completing 73% of them. While deal count falls, aggregate value has concentrated in a handful of platform sales:

    AcquirerTargetDeal ValueHeadline MultipleYear
    AonUSI (pending)$17.0B~14.5x synergized EBITDA2026
    Arthur J. GallagherAssuredPartners$13.45B14.3x EBITDAC (11.3x net)2025
    AonNFP Corp.$13.4B~15x seller-adjusted EBITDA2024
    Brown & BrownAccession Risk Management$9.8B~16.4x EBITDA (~12x with synergies)2025
    Marsh McLennanMcGriff Insurance$7.75BNot disclosed (~6x revenue)2024

    These five deals total over $61 billion, the core of the insurance brokerage consolidation wave. Read the multiples carefully: Aon's USI announcement quotes about 14.5x trailing EBITDA only after counting expected synergies, and Gallagher's AssuredPartners release shows 14.3x gross but 11.3x net of a $1 billion deferred tax asset and synergies.

    PE in Insurance Brokerage

    Private equity has transformed insurance brokerage into one of the most active roll-up sectors in all of financial services. The structural appeal is clear: sticky customer bases (high retention rates), recurring commission revenue, high EBITDA margins, low capital expenditure requirements, and a fragmented market with thousands of independent agencies available for acquisition.

    The leading PE-backed platforms, ranked sixth, seventh and ninth in AM Best's global broker ranking by 2025 revenue, include:

    • Alliant Insurance Services ($5.8 billion revenue, 2025): Backed by Stone Point Capital, KKR and PSP Investments.
    • Hub International ($5.28 billion revenue, 2025): Controlled by Hellman & Friedman, with Altas Partners and Leonard Green & Partners as significant minority shareholders. A $1.6 billion minority investment led by T. Rowe Price, Alpha Wave Global and Temasek valued it at $29 billion in May 2025.
    • Acrisure ($4.82 billion revenue, 2025): Majority employee-owned. A $2.1 billion raise led by Bain Capital valued it at $32 billion in May 2025, about 40% above its previous round.

    These platforms complete dozens of tuck-in acquisitions a year (OPTIS counted 49 for Hub and 20 for Acrisure in 2025), but the pace is slowing. OPTIS counted 439 agency deals in the first nine months of 2026, down 19% year on year, with PE-backed and hybrid buyers still behind 76% of them. Thinner arbitrage has made buyer selectivity the norm.

    MGA M&A: The PE Sweet Spot

    Managing General Agents occupy a unique position that combines the capital-light profile of brokers with the underwriting authority of carriers. MGAs write and bind policies on behalf of insurance carriers, earning override commissions and sometimes profit-sharing arrangements. Conning estimates US MGA premium reached about $128 billion in 2025 including Lloyd's business, while statutory MGA direct premium written grew 12% to $102.6 billion.

    Private equity has become a major owner of US MGAs. The appeal mirrors the broker roll-up thesis (capital-light, high margins, recurring revenue) with an additional growth dimension: MGAs are expanding into underserved lines where traditional carriers are pulling back, particularly specialty, cyber, and excess & surplus (E&S) coverage. Buyers pay for that growth: L.E.K. Consulting found that MGA deal multiples in the US and UK rose from about 12x EBITDA in 2017 to about 15x in 2023, with a wide spread depending on how differentiated the underwriting is.

    Recent MGA transactions include New Mountain Capital's purchase of Carlyle-owned NSM Insurance Group's US commercial division (closed April 2025 and renamed Novacore), and Acrisure's December 2025 agreement to buy Vave, a tech-first E&S property MGA, from Canopius for its Acrisure Underwriting platform.

    How the Two Types Differ in Practice

    DimensionUnderwriter DealBroker Deal
    Primary valuationEmbedded value, P/BV, loss ratiosEV/EBITDA or EBITDAC (about 11-16x)
    Balance sheetCentral (reserves, capital)Peripheral (minimal assets)
    Revenue modelPremiums, investment incomeCommissions, advisory fees
    Capital requirementsSignificant (RBC, Solvency II)Minimal
    Buyer universeStrategic carriers, reinsurers, foreign insurersPE sponsors, public brokers
    Synergy typeRisk diversification, reinsurance optimization, capital efficiencyOperational (back-office, technology, cross-sell)
    Due diligence focusReserve adequacy, asset quality, claims trendsRevenue retention, client concentration, organic growth
    PE involvementLimited (strategic buyers dominate)Dominant (73% of 2025 agency deals)

    For FIG bankers, the choice of advisory approach is binary. A carrier deal requires actuarial expertise, reserve analysis, regulatory capital modeling, and cross-border regulatory navigation. A broker deal requires EBITDA normalization, customer retention analysis, integration planning, and financial sponsor relationships. The skill sets overlap less than in almost any other FIG transaction type.

    Insurance M&A generates some of the most significant advisory fees in FIG investment banking. The combination of carrier M&A complexity (actuarial analysis, regulatory approvals, cross-border structuring) and broker M&A volume (hundreds of transactions annually across PE platforms) creates a deep, sustained deal flow that is a major component of every FIG group's revenue.

    Interview Questions

    1
    Question #1Medium

    How do insurance company M&A deals differ between underwriter acquisitions and broker/MGA rollups?

    These are fundamentally different deal types within insurance M&A:

    Underwriter acquisitions:

    • •Valuation: P/BV (roughly 1.5-2x for P&C, around 1x for US life), P/E (roughly 10-12x for P&C); European life insurers also trade on P/EV
    • •Key concern: Reserve adequacy. The acquirer must assess whether the target's loss reserves are sufficient. Reserve deficiency is the single biggest risk in insurance M&A. Independent actuarial review is mandatory.
    • •Capital impact: Creates goodwill that may affect RBC ratios. The acquirer inherits the target's underwriting risk and investment portfolio.
    • •Synergies: Primarily cost-driven (duplicate underwriting, claims, IT infrastructure). Revenue synergies are limited because policyholders can shop at renewal.
    • •Deal timeline: Requires Form A approval from the insurance regulator in each insurer's state of domicile, plus pre-acquisition (Form E) filings in states where the combined market share crosses thresholds. A group with several insurance subsidiaries can need many approvals, so these deals take months.

    Broker/MGA rollups:

    • •Valuation: Scaled broker and MGA platforms have sold for mid-to-high teens EBITDA in M&A, driven up by competition between PE and strategic buyers.
    • •Asset-light model. Brokers and MGAs do not hold reserves or bear underwriting risk. They earn commissions or managing agent fees.
    • •Roll-up economics: PE-backed platforms (Acrisure, Hub International, Alliant) buy small agencies at lower multiples than the platform itself commands, so each add-on is accretive. That gap has narrowed as agency prices rose, and some PE-built platforms (AssuredPartners, NFP) have since been sold to strategic brokers.
    • •Revenue synergies are real. Brokers can cross-sell across the combined client base, negotiate better carrier commissions with scale, and share best practices.
    • •Less regulatory friction. No insurance commissioner approval needed in most cases (no change of control of an underwriting entity).
    Rate yourself:

    Explore More

    How to Value a Bank: FIG Valuation Explained

    How to value a bank when EV/EBITDA breaks down: master P/TBV, ROE, the justified P/B formula, and the dividend discount model for FIG interviews.

    July 20, 2026

    Buybacks vs Dividends: How Companies Return Cash

    Buybacks vs dividends explained: how each returns cash to shareholders, the tax and signaling differences, the EPS effect, and when each makes sense.

    June 25, 2026

    Why Are Investment Banking Bonuses So High?

    Why investment banking bonuses are so high: the revenue-per-head economics, the compensation ratio, why pay is bonus-heavy and cyclical, and the real catch.

    May 27, 2026

    Ready to Transform Your Interview Prep?

    Join 5,000+ students preparing smarter

    Join 10,000+ students who have downloaded this resource